Article

Geisinger Partners With LHC Group for Home Health and Hospice Joint Venture

Geisinger Home Health and Hospice, LHC Group, and AtlantiCare Home Health and Hospice have announced a joint venture to enhance home health and hospice services.

Geisinger Home Health and Hospice, LHC Group, and AtlantiCare Home Health and Hospice have announced a joint venture to enhance home health and hospice services at Geisinger locations in Pennsyvlania and at AtlantiCare—a member of Geisinger in Atlantic County, New Jersey. The agreement is expected to be finalized by April 1 for Pennsylvania locations and by June 1 for New Jersey.

The home healthcare service is available 24/7 for home healthcare visits and for end-of-life care. Read more about the joint venture.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!
Related Videos
David Awad, PharmD, BCOP
Merrill H. Stewart, MD
Andrew Evens, DO, MBA, MSc, deputy director for clinical services and chief physician officer, Rutgers Cancer Institute and Jack & Sheryl Morris Cancer Center
Hamlet Gasoyan, PhD
Dr Matthew Matasar
Dr Marina Kremskayana
Dr Sundar Jagannath
David Awad, PharmD, BCOP
Andrew Kuykendall, MD, Moffitt Cancer Center
Merrill H. Stewart, MD
Related Content
taxes Image Credit - maxsim - stock.adobe.com
June 13th 2025

Is the Employer Health Care Tax Exclusion Safe? Kerris Willis Shares Insight From American Benefits Council

Giuliana Grossi
While the tax exclusion for employer-sponsored health care was not included in the House-passed reconciliation bill, it remains a revenue target for Congress, risking inclusion in the Senate's version.
Managed Care Cast
May 27th 2025

Frameworks for Advancing Health Equity: Social Work and Complex Care Navigation

Giuliana Grossi Victor Murray, MSW
Victor Murray, MSW, of the Camden Coalition, delves into the evolving role of social workers, focusing on advocacy, systems change, and addressing health disparities in underserved communities.
Acute myeloid leukemia cells | Image credit: LASZLO - stock.adobe.com
June 12th 2025

Revumenib Shows Efficacy in Patients With AML and Genetic Alterations

Laura Joszt, MA
Revumenib shows promise for high-risk patients with acute myeloid leukemia (AML) with specific genetic mutations, demonstrating efficacy with no new safety signals.
Managed Care Cast
May 20th 2025

Mental Health Awareness: Transforming Workplace Support and Engagement

Giuliana Grossi Jim Kinville
Explore how employers enhance workplace mental health by fostering a culture of support and engagement, focusing on holistic well-being strategies in this interview with Jim Kinville, MA, University of Pittsburgh Medical Center.
Tirzepatide injections in box | Image credit: MKPhoto – stock.adobe.com
June 10th 2025

Real-World Use of GLP-1s Yields Less Weight Loss Than Clinical Trials

Hayden E. Klein
Patients who remained on treatment, especially at higher doses or on tirzepatide, were more likely to achieve clinically meaningful weight loss and improved glycemic control.
Inflation Reduction Act | Image Credit: wladimir1804-stock.adobe.com
May 31st 2025

Community Oncology Bracing for IRA Impact

Maggie L. Shaw
Community oncology faces significant challenges from the Inflation Reduction Act's (IRA) drug pricing changes, risking financial stability and patient access to care.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo